ArticleBiologics : targets & therapy2009

New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Ara Metjian et al.PubMed ↗Full text ↗

No numbers read from the abstract.